(OLPX) Olaplex Holdings - Ratings and Ratios
Hair Bonding Products, Shampoo, Conditioner, Treatments
OLPX EPS (Earnings per Share)
OLPX Revenue
Description: OLPX Olaplex Holdings
Olaplex Holdings Inc. (NASDAQ: OLPX) operates in the U.S. personal care sector, focusing on premium hair‑care chemistry sold through professional salons, e‑commerce, and mass‑retail partners. The brand’s core proposition—bond‑repair technology—commands higher price points and drives repeat purchase cycles, underpinning its gross margin profile, which historically hovers around 70% on product sales.
Revenue growth is the primary KPI: the company posted a compound annual growth rate (CAGR) of roughly 30% over the past three fiscal years, propelled by international market penetration (Europe and Asia‑Pacific) and expanding salon distribution. Same‑store sales in the U.S. channel have been positive YoY, reflecting a rebound in discretionary salon spending post‑pandemic.
Operating efficiency is measured by EBITDA margin, which has been volatile due to aggressive marketing spend and inventory buildup. Recent quarterly filings show an EBITDA margin of -5%, indicating that the firm is still in a growth‑investment phase, with cash burn approximating $40 million per quarter. The balance sheet holds roughly $250 million of cash and short‑term investments, providing runway for product rollout and channel expansion without immediate reliance on external financing.
Key economic drivers include consumer confidence in the discretionary segment, salon traffic recovery, and the premiumization trend in hair care. Raw material cost inflation (e.g., specialty polymers) and supply‑chain constraints can pressure cost of goods sold, while currency fluctuations affect overseas revenue. The company’s ability to lock in long‑term supply contracts and hedge foreign exchange exposure is a material risk mitigant.
Strategic levers: (1) deepen salon partnerships to increase unit volume per location; (2) expand direct‑to‑consumer digital sales, which currently represent ~15% of total revenue but have a higher contribution margin; (3) launch new product extensions leveraging the existing bond‑repair platform to capture adjacent categories such as color‑treatment and styling aids; (4) pursue selective acquisitions of niche brands to broaden the portfolio and accelerate international market share.
Financial health indicators: debt‑to‑equity remains below 0.2, reflecting minimal leverage; free cash flow is negative but trending toward breakeven as marketing efficiency improves. The forward price‑to‑earnings multiple of ~27× suggests the market prices future profitability, contingent on sustained top‑line momentum and margin expansion.
OLPX Stock Overview
Market Cap in USD | 914m |
Sub-Industry | Personal Care Products |
IPO / Inception | 2021-09-30 |
OLPX Stock Ratings
Growth Rating | -85.0% |
Fundamental | 42.3% |
Dividend Rating | - |
Return 12m vs S&P 500 | -43.9% |
Analyst Rating | 2.89 of 5 |
OLPX Dividends
Currently no dividends paidOLPX Growth Ratios
Growth Correlation 3m | 12.1% |
Growth Correlation 12m | -76.3% |
Growth Correlation 5y | -94.4% |
CAGR 5y | -51.76% |
CAGR/Max DD 5y | -0.54 |
Sharpe Ratio 12m | -0.06 |
Alpha | -53.42 |
Beta | 1.231 |
Volatility | 77.03% |
Current Volume | 535.2k |
Average Volume 20d | 709k |
Stop Loss | 1.3 (-9.1%) |
Signal | -0.86 |
Piotroski VR‑10 (Strict, 0-10) 3.5
Net Income (-1.28m TTM) > 0 and > 6% of Revenue (6% = 25.4m TTM) |
FCFTA 0.07 (>2.0%) and ΔFCFTA -2.45pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 81.01% (prev 133.3%; Δ -52.25pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.07 (>3.0%) and CFO 101.1m > Net Income -1.28m (YES >=105%, WARN >=100%) |
Net Debt (62.6m) to EBITDA (113.2m) ratio: 0.55 <= 3.0 (WARN <= 3.5) |
Current Ratio 3.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (666.0m) change vs 12m ago 0.36% (target <= -2.0% for YES) |
Gross Margin 68.90% (prev 64.38%; Δ 4.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 25.85% (prev 24.94%; Δ 0.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 1.06 (EBITDA TTM 113.2m / Interest Expense TTM 56.6m) >= 6 (WARN >= 3) |
Altman Z'' 3.77
(A) 0.23 = (Total Current Assets 462.7m - Total Current Liabilities 119.9m) / Total Assets 1.52b |
(B) 0.36 = Retained Earnings (Balance) 538.7m / Total Assets 1.52b |
(C) 0.04 = EBIT TTM 60.0m / Avg Total Assets 1.64b |
(D) 0.84 = Book Value of Equity 538.7m / Total Liabilities 642.8m |
Total Rating: 3.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 42.33
1. Piotroski 3.50pt = -1.50 |
2. FCF Yield 9.10% = 4.55 |
3. FCF Margin 23.58% = 5.89 |
4. Debt/Equity 0.54 = 2.36 |
5. Debt/Ebitda 4.17 = -2.50 |
6. ROIC - WACC -4.61% = -5.76 |
7. RoE -0.15% = -0.02 |
8. Rev. Trend -71.78% = -3.59 |
9. Rev. CAGR -16.84% = -2.50 |
10. EPS Trend -83.85% = -2.10 |
11. EPS CAGR -31.70% = -2.50 |
What is the price of OLPX shares?
Over the past week, the price has changed by +2.14%, over one month by -4.67%, over three months by +8.33% and over the past year by -34.40%.
Is Olaplex Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OLPX is around 0.84 USD . This means that OLPX is currently overvalued and has a potential downside of -41.26%.
Is OLPX a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 8
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the OLPX price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 2 | 39.2% |
Analysts Target Price | 2.1 | 44.1% |
ValueRay Target Price | 0.9 | -35% |
Last update: 2025-08-21 02:50
OLPX Fundamental Data Overview
CCE Cash And Equivalents = 289.3m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 27.3973
P/S = 2.1601
P/B = 1.0454
Beta = 2.332
Revenue TTM = 423.1m USD
EBIT TTM = 60.0m USD
EBITDA TTM = 113.2m USD
Long Term Debt = 351.9m USD (from longTermDebt, last quarter)
Short Term Debt = 119.9m USD (from totalCurrentLiabilities, last quarter)
Debt = 471.8m USD (Calculated: Short Term 119.9m + Long Term 351.9m)
Net Debt = 62.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.10b USD (913.9m + Debt 471.8m - CCE 289.3m)
Interest Coverage Ratio = 1.06 (Ebit TTM 60.0m / Interest Expense TTM 56.6m)
FCF Yield = 9.10% (FCF TTM 99.7m / Enterprise Value 1.10b)
FCF Margin = 23.58% (FCF TTM 99.7m / Revenue TTM 423.1m)
Net Margin = -0.30% (Net Income TTM -1.28m / Revenue TTM 423.1m)
Gross Margin = 68.90% ((Revenue TTM 423.1m - Cost of Revenue TTM 131.6m) / Revenue TTM)
Tobins Q-Ratio = 2.04 (Enterprise Value 1.10b / Book Value Of Equity 538.7m)
Interest Expense / Debt = 2.62% (Interest Expense 12.4m / Debt 471.8m)
Taxrate = 27.46% (from yearly Income Tax Expense: 7.39m / 26.9m)
NOPAT = 43.5m (EBIT 60.0m * (1 - 27.46%))
Current Ratio = 3.86 (Total Current Assets 462.7m / Total Current Liabilities 119.9m)
Debt / Equity = 0.54 (Debt 471.8m / last Quarter total Stockholder Equity 874.2m)
Debt / EBITDA = 4.17 (Net Debt 62.6m / EBITDA 113.2m)
Debt / FCF = 4.73 (Debt 471.8m / FCF TTM 99.7m)
Total Stockholder Equity = 876.7m (last 4 quarters mean)
RoA = -0.08% (Net Income -1.28m, Total Assets 1.52b )
RoE = -0.15% (Net Income TTM -1.28m / Total Stockholder Equity 876.7m)
RoCE = 4.88% (Ebit 60.0m / (Equity 876.7m + L.T.Debt 351.9m))
RoIC = 2.99% (NOPAT 43.5m / Invested Capital 1.45b)
WACC = 7.61% (E(913.9m)/V(1.39b) * Re(10.55%)) + (D(471.8m)/V(1.39b) * Rd(2.62%) * (1-Tc(0.27)))
Shares Correlation 5-Years: -90.0 | Cagr: -0.99%
Discount Rate = 10.55% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.86% ; FCFE base≈123.3m ; Y1≈102.4m ; Y5≈75.0m
Fair Price DCF = 1.41 (DCF Value 940.6m / Shares Outstanding 667.1m; 5y FCF grow -20.43% → 3.0% )
Revenue Correlation: -71.78 | Revenue CAGR: -16.84%
Rev Growth-of-Growth: 16.35
EPS Correlation: -83.85 | EPS CAGR: -31.70%
EPS Growth-of-Growth: -74.24
Additional Sources for OLPX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle